Knowles (KN) Q1 2026 Earnings Call Transcript

Knowles reported Q1 revenue of $153 million, up 16% year over year, with EPS of $0.27 rising 50% and both metrics at or above guidance. MedTech and Specialty Audio revenue grew 14% to $68 million with gross margin expanding 480 bps to 53.5%, while Precision Devices revenue rose 17% to $85 million and gross margin improved 350 bps to 39.2% on better pricing and utilization. Management raised its confidence in 2026, guiding Q2 revenue to $152 million-$162 million and EPS to $0.28-$0.32, while expecting at least 100 bps full-year gross margin improvement in Precision Devices and continued momentum from the $75 million-plus energy order.

Analysis

KN is moving from a “prove it” story to a self-funding operating leverage story, but the market may still be underappreciating how much of the upside is now embedded in mix and utilization rather than sheer top-line growth. The key inflection is that the Precision Devices business appears to have enough pricing discipline and capacity slack to convert incremental demand into margin with limited capex, which is a much more attractive earnings model than a normal industrial cyclical. That matters because it reduces the probability that the next leg of growth gets absorbed by working capital or heavy plant investment.

The hidden second-order beneficiary is the defense/electrification supplier ecosystem: if KN is seeing multi-year discussions and tighter customer planning, smaller upstream vendors that depend on its volume may get pulled into longer-duration demand visibility as well. Conversely, competitors selling commoditized RF/film components should feel pressure, because KN is signaling it can selectively walk away from price-sensitive business while still filling capacity with higher-return orders. That usually forces weaker peers either to chase share at lower margins or miss the cycle entirely.

The biggest near-term risk is not demand; it is execution on the specialty film ramp. The stock likely trades on the assumption that the energy-order margin drag disappears by the back half, so any slip in qualification, yield, or labor scaling would hit both the 2026 margin bridge and credibility on 2027 earnings power. A less obvious risk is that management’s confidence invites multiple expansion before the operating model has fully de-risked, making the name vulnerable to a sharp reset if Q2/Q3 margins merely meet rather than exceed guide.

Consensus may be underestimating the durability of pricing in PD. Management is effectively saying this is not a one-off reprice, but a recurring annual lever, which can add a low-single-digit percentage point to EBIT conversion over time when combined with higher utilization. If that cadence holds, the stock should increasingly be valued on mid-cycle margin power rather than near-term revenue growth, which is a materially higher multiple regime.

Key Decisions for Investors

• Long KN for a 3-6 month horizon: attractive if the market is still pricing it as a normal cyclical; upside comes from margin compounding and de-risking of the specialty film ramp, with downside mainly tied to execution slippage.
• Buy KN on any post-earnings pullback toward guidance support; use a stop tied to evidence of delayed energy-order ramp or Q2 gross margin miss, since that is the cleanest catalyst for a multiple reset.
• Relative value: long KN / short a commoditized electronics components peer basket over 1-2 quarters; thesis is KN’s pricing power and mix are better insulated than low-differentiation suppliers exposed to the same end markets.
• For higher-risk exposure, consider KN call spreads 3-6 months out to express upside from back-half margin expansion while limiting premium decay if the stock has already priced in the “great quarter” narrative.
• Monitor for a 2027 re-rating: if management reiterates annual 2%-4% pricing in PD and margins continue to expand into year-end, add on weakness rather than chasing strength; that combination can justify a durable multiple expansion.